CBT · trading date Oct 12, 2026 · previous close $74.95 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$3.71B
Net income
$331.00M
Total assets
$3.82B
Total liabilities
—
Stockholders' equity
$1.55B
Cash & equivalents
$258.00M
Operating income
$621.00M
Operating cash flow
$665.00M
Capital expenditures
$274.00M
Fiscal year 2025, via 10-K filed 2025-11-24.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
16.7%
Net margin
8.9%
Free cash flow
$391.00M
Free cash flow margin
10.5%
Liabilities / assets
—
Equity / assets
40.6%
CapEx / revenue
7.4%
Operating cash flow / net income
2.01×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Boston, MA 02210
TWO SEAPORT LANE SUITE 1400
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.